{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:32:41Z","timestamp":1790857961764,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.autrev.2023.103442","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T10:27:01Z","timestamp":1693996021000},"page":"103442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation"],"prefix":"10.1016","volume":"22","author":[{"given":"Amy","family":"Paskiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103442_bb0005","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1182\/blood-2011-07-325217","article-title":"How I treat autoimmune lymphoproliferative syndrome","volume":"118","author":"Rao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0010","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.4049\/jimmunol.1100021","article-title":"FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome","volume":"186","author":"Kuehn","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0015","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0020","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood-2014-03-564286","article-title":"Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency","volume":"124","author":"Rensing-Ehl","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0030","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2004-09-3542","article-title":"Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)","volume":"105","author":"Teachey","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0035","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.pas.0000157997.61177.08","article-title":"Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome","volume":"29","author":"Maric","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.autrev.2023.103442_bb0040","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","article-title":"Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations","volume":"123","author":"Price","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"issue":"Pt 3","key":"10.1016\/j.autrev.2023.103442_bb0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1042\/bj3100957","article-title":"Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation","volume":"310","author":"Liu","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2023.103442_bb0055","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.autrev.2023.103442_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/JLB.5MR0817-332R","article-title":"Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients","volume":"103","author":"Ben-Mustapha","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2023.103442_bb0065","first-page":"388","article-title":"The genetic landscape of the FAS pathway deficiencies","volume":"44","author":"Magerus","year":"2021","journal-title":"Biom J"},{"key":"10.1016\/j.autrev.2023.103442_bb0070","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/intimm\/6.10.1567","article-title":"Human Fas ligand: gene structure, chromosomal location and species specificity","volume":"6","author":"Takahashi","year":"1994","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fimmu.2017.00403","article-title":"Dual role of Fas\/FasL-mediated signal in peripheral immune tolerance","volume":"8","author":"Yamada","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0080","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1681\/ASN.2014121214","article-title":"Double-negative \u03b1\u03b2 T cells are early responders to AKI and are found in human kidney","volume":"27","author":"Martina","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2023.103442_bb0085","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood-2004-07-2583","article-title":"Isolation and characterization of human antigen-specific TCR\u03b1\u03b2+ CD4-CD8- double-negative regulatory T cells","volume":"105","author":"Fischer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0090","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crisp\u00edn","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2014.01.030","article-title":"CD4\u2212CD8\u2212 T-cells in primary Sj\u00f6gren\u2019s syndrome: association with the extent of glandular involvement","volume":"51","author":"Alunno","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103442_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2017.06.002","article-title":"TCR+CD3+CD4\u2212CD8\u2212 effector T cells in psoriasis","volume":"181","author":"Brandt","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/JLB.1AB0120-548R","article-title":"TCR-\u03b1\/\u03b2 CD4(\u2212) CD8(\u2212) double negative T cells arise from CD8(+) T cells","volume":"108","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2023.103442_bb0110","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4049\/jimmunol.149.4.1211","article-title":"Cytokine production by mature and immature CD4-CD8- T cells alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4","volume":"149","author":"Zlotnik","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0115","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.4049\/jimmunol.1402775","article-title":"Programmed cell death 1 and Helios distinguish TCR-\u03b1\u03b2+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells","volume":"194","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4049\/jimmunol.181.1.440","article-title":"Human TCR alpha\/beta+ CD4-CD8- double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vbeta TCR diversity and are clonally related to CD8+ T cells","volume":"181","author":"Bristeau-Leprince","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0125","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood.V97.10.3161","article-title":"Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression","volume":"97","author":"Lopatin","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.clinbiochem.2012.01.016","article-title":"Elevated vitamin B\u2081\u2082 levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes","volume":"45","author":"Bowen","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.autrev.2023.103442_bb0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clim.2014.10.006","article-title":"A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome","volume":"155","author":"Nabhani","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0140","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2012.06.011","article-title":"Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation","volume":"131","author":"Magerus-Chatinet","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/pr.2015.170","article-title":"Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation","volume":"78","author":"Ruiz-Garc\u00eda","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2023.103442_bb0150","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2006-04-015776","article-title":"A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome","volume":"108","author":"Del-Rey","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0155","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jaci.2015.08.025","article-title":"Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly","volume":"137","author":"Sobh","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2350-8-41","article-title":"Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) type Ib","volume":"8","author":"Bi","year":"2007","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.autrev.2023.103442_bb0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00439-006-0138-9","article-title":"Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome","volume":"119","author":"Zhu","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.autrev.2023.103442_bb0170","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s11882-014-0462-4","article-title":"Autoimmune lymphoproliferative syndrome: an update and review of the literature","volume":"14","author":"Shah","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.autrev.2023.103442_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fped.2015.00065","article-title":"Approaches to managing autoimmune cytopenias in novel immunological disorders with genetic underpinnings like autoimmune lymphoproliferative syndrome","volume":"3","author":"Rao","year":"2015","journal-title":"Front Pediatr"},{"key":"10.1016\/j.autrev.2023.103442_bb0180","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1084\/jem.192.12.1833","article-title":"Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction","volume":"192","author":"M\u00fcschen","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2023.103442_bb0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0609.2007.00924.x","article-title":"Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS7+2 T>C) affecting the Fas gene","volume":"79","author":"Wei","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.autrev.2023.103442_bb0190","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0195","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0042-9007.2003.00374.x","article-title":"Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome","volume":"85","author":"Kwon","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.autrev.2023.103442_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V79.1.45.45","article-title":"Glucocorticoids downregulate gene expression of GM-CSF, NAP-1\/IL-8, and IL-6, but not of M-CSF in human fibroblasts","volume":"79","author":"Tobler","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0205","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.4049\/jimmunol.170.9.4833","article-title":"Inhibition of IFN-gamma signaling by glucocorticoids","volume":"170","author":"Hu","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/intimm\/6.3.431","article-title":"Involvement of protein kinase C-epsilon in glucocorticoid-induced apoptosis in thymocytes","volume":"6","author":"Iwata","year":"1994","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0215","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MPH.0b013e31802d7503","article-title":"Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome","volume":"28","author":"Kossiva","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.autrev.2023.103442_bb0220","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2005.05496.x","article-title":"Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome","volume":"129","author":"Rao","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2023.103442_bb0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.07595.x","article-title":"Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome","volume":"145","author":"Teachey","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2023.103442_bb0230","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/blood-2014-06-582346","article-title":"Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients","volume":"124","author":"Khellaf","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0235","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2796.2009.02126.x","article-title":"Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study","volume":"266","author":"Dierickx","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2023.103442_bb0240","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2350\/06-06-0105.1","article-title":"Autoimmune lymphoproliferative syndrome (ALPS): a case with congenital onset","volume":"10","author":"Kahwash","year":"2007","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.autrev.2023.103442_bb0245","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bmt.1705775","article-title":"Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion","volume":"40","author":"Dimopoulou","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.autrev.2023.103442_bb0250","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/eji.1830270831","article-title":"Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation","volume":"27","author":"Benkerrou","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0255","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.bmt.1701306","article-title":"Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation","volume":"22","author":"Sleight","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.autrev.2023.103442_bb0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/gim.0b013e3182310b7d","article-title":"Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance","volume":"14","author":"Hsu","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.autrev.2023.103442_bb0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2172-8-28","article-title":"Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome","volume":"8","author":"Cerutti","year":"2007","journal-title":"BMC Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0270","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3324\/haematol.2012.067488","article-title":"Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults","volume":"98","author":"Lambotte","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2023.103442_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clim.2017.06.009","article-title":"Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome","volume":"183","author":"Agrebi","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103442_bb0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1203\/PDR.0b013e318191f7e4","article-title":"Residual CD95-pathway function in children with autoimmune lymphoproliferative syndrome is independent from clinical state and genotype of CD95 mutation","volume":"65","author":"Fuchs","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2023.103442_bb0285","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/302333","article-title":"Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance","volume":"64","author":"Jackson","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2023.103442_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.624116","article-title":"Case report: a novel pathogenic missense mutation in FAS: a multi-generational case series of autoimmune lymphoproliferative syndrome","volume":"9","author":"Gaefke","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.autrev.2023.103442_bb0295","first-page":"2575","article-title":"Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations","volume":"94","author":"Rieux-Laucat","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103442_bb0300","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1203\/00006450-200003000-00009","article-title":"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?","volume":"47","author":"van der Burg","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2023.103442_bb0305","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2023.103442_bib306","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:29:39Z","timestamp":1761600579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1568997223001763"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103442","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103442"}}